EUVIMEDEUVIMED entdecken
Crossref

(2-Methylbutyryl)shikonin Naturally Occurring Shikonin Derivative Ameliorates the α-MSH-Induced Melanogenesis via ERK1/2 and p38 MAP Kinase-Mediated Down-Regulation of the MITF Transcription Factor

Aalim Maqsood Bhat iD, Rashid Haroon, Shahid Naikoo, Raghu Rai Sharma iD, Sajeeda Archoo, Sheikh A Tasduq iD

Chemical Research in Toxicology · 2024

DOI: 10.1021/acs.chemrestox.3c00283 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemical Research in Toxicology, 2024. Verfasst von Aalim Maqsood Bhat und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pharmacology Division, Council of Scientific and Industrial Research-Indian Institute of Integrative Medicine, Jammu, Jammu and Kashmir 180001, India. Hauptthemen laut MEDLINE: Hypopigmentation, Melanoma, Experimental, Naphthoquinones. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Council of Scientific and Industrial Research, India, University Grants Commission, Department of Science and Technology, Ministry of Science and Technology, India.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cutaneous pigmentation is an important phenotypic trait whose regulation, despite recent advances, has yet to be completely elucidated. Melanogenesis, a physiological process of melanin production, is imperative for organism survival as it provides protection against the environmental insults that majorly involve sunlight-induced skin photodamage. However, immoderate melanin synthesis can cause pigmentation disorders associated with a psychosocial impact. In this study, the hypopigmentation effect of (2-methylbutyryl)shikonin, a natural product present in the root extract of Lithospermum erythrorhizon, and the underlying mechanisms responsible for the inhibition of melanin synthesis in α-MSH-stimulated B16F10 cells and C57BL/6J mice was studied. Non-cytotoxic concentrations of (2-methylbutyryl)shikonin significantly repressed cellular tyrosinase activity and melanin synthesis in both in vitro and in vivo models (C57BL/6J mice). (2-Methylbutyryl)shikonin remarkably abolished the protein expression of MITF, tyrosinase, tyrosinase-related protein 1, and tyrosinase-related protein 2, thereby blocking the production of pigment melanin via modulating the phosphorylation status of MAPK proteins, viz., ERK1/2 and p38. In addition, specific inhibition of ERK1/2 attenuated the inhibitory effects of (2-methylbutyryl)shikonin on melanin synthesis, whereas selective inhibition of p38 augmented the inhibitory effect of BSHK on melanin synthesis. Moreover, topical application of (2-methylbutyryl)shikonin on C57BL/6J mouse tails remarkably induced tail depigmentation. In conclusion, with these findings, we, for the first time, report the hypopigmentation effect of (2-methylbutyryl)shikonin via inhibition of cellular tyrosinase enzyme activity, subsequently ameliorating the melanin production, thereby indicating that (2-methylbutyryl)shikonin is a potential natural therapy for hyperpigmentation disorders.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypopigmentationMelanoma, ExperimentalNaphthoquinonesAnimalsMicep38 Mitogen-Activated Protein KinasesMonophenol MonooxygenaseDown-RegulationMicrophthalmia-Associated Transcription Factoralpha-MSHSignal TransductionMelanogenesisMelaninsMAP Kinase Signaling SystemCell Line, TumorMice, Inbred C57BL

Substanzen

p38 Mitogen-Activated Protein KinasesMonophenol MonooxygenaseMicrophthalmia-Associated Transcription Factoralpha-MSHshikoninMelaninsNaphthoquinones

Autor:innen und Institutionen

  • Pharmacology Division, Council of Scientific and Industrial Research-Indian Institute of Integrative Medicine, Jammu, Jammu and Kashmir 180001, India.
  • Academy of Scientific and Innovative Research (AcSIR), Ghaziabad, Uttar Pradesh 201002, India.
  • Sher-e-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir 190011, India.

ORCID-Profile: Aalim Maqsood Bhat, Raghu Rai Sharma, Sheikh A Tasduq

Förderung

  • Council of Scientific and Industrial Research, India
  • University Grants Commission
  • Department of Science and Technology, Ministry of Science and Technology, India

Zitieren

APA

Bhat, A. M., Haroon, R., Naikoo, S., Sharma, R. R., Archoo, S., & Tasduq, S. A. (2024). (2-Methylbutyryl)shikonin Naturally Occurring Shikonin Derivative Ameliorates the α-MSH-Induced Melanogenesis via ERK1/2 and p38 MAP Kinase-Mediated Down-Regulation of the MITF Transcription Factor. Chemical Research in Toxicology. https://doi.org/10.1021/acs.chemrestox.3c00283

Vancouver

Bhat AM, Haroon R, Naikoo S, Sharma RR, Archoo S, Tasduq SA. (2-Methylbutyryl)shikonin Naturally Occurring Shikonin Derivative Ameliorates the α-MSH-Induced Melanogenesis via ERK1/2 and p38 MAP Kinase-Mediated Down-Regulation of the MITF Transcription Factor. Chemical Research in Toxicology. 2024. doi:10.1021/acs.chemrestox.3c00283

BibTeX
@article{Bhat2024,
  author = {Bhat, Aalim Maqsood and Haroon, Rashid and Naikoo, Shahid and Sharma, Raghu Rai and Archoo, Sajeeda and Tasduq, Sheikh A},
  title = {(2-Methylbutyryl)shikonin Naturally Occurring Shikonin Derivative Ameliorates the α-MSH-Induced Melanogenesis via ERK1/2 and p38 MAP Kinase-Mediated Down-Regulation of the MITF Transcription Factor},
  journal = {Chemical Research in Toxicology},
  year = {2024},
  doi = {10.1021/acs.chemrestox.3c00283}
}
Kostenlos starten →